TriNet has been proven to be very sensitive in detecting ACPs and AMPs, demonstrating its great potential for guiding the development of small-peptide drugs targeting cancer cells or other pathogens, such as bacteria, fungi, and viruses. This evidence concerns the gene AASDHPPT and cancer.